FDA and DEA warn online pharmacies illegally selling ADHD drug Adderall

pharmafile | April 13, 2022 | News story | Research and Development  

The FDA and the US DEA have jointly issued warning letters to operators of two websites illegally selling Schedule II stimulants, including amphetamine drug products marked as Adderall, a treatment for attention deficit hyperactivity disorder (ADHD).

These websites sell the medication online without a prescription, which places consumers at risk, the FDA shared in a press release.

“This action underscores the FDA’s commitment to use all available regulatory and compliance tools to stop online businesses illegally selling potentially harmful drug products to consumers,” said FDA Commissioner Robert M. Califf, M.D. “The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse and overdose. These particular types of online pharmacies also undermine our efforts to help consumers safely purchase legitimate prescription medicines over the internet.  FDA will continue partnering with DEA in an effort to safeguard public health and protect consumers who need access to these important medicines.”

Adderall is an FDA-approved prescription drug made of two stimulants – amphetamine and dextroamphetamine – and has a high potential for abuse and addiction.

The FDA also shared that the sites selling Adderall with no prescription pose a risk as, while being marketed as authentic, the drug may be counterfeit, contaminated, expired, “or otherwise harmful”.

“These letters are not only a warning to the companies that illegally sell prescription medications, but they also serve as a warning to consumers who have bought or have considered buying medications online without a legitimate prescription,” said DEA Administrator Anne Milgram. “Consumers cannot trust the safety or legitimacy of pills sold on unaccredited sites. DEA strongly urges anyone seeking controlled medications to obtain a prescription from a trusted medical professional and have it dispensed by a licensed pharmacy.  We will continue working closely with our FDA partners to protect the integrity of the prescription drug supply chain and ensure the safety and health of our communities.”

The FDA has advised that consumers should safely disposed of unused medicine from these sites, urging consumers to obtain prescription drugs from state-licensed US pharmacies or physicians, where state authorities can assure the quality of drug manufacturing, packaging, distribution, and labelling.

Ana Ovey

Related Content

No items found

Latest content